step 6 semaglutide Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial 🚨 STEP UP Trial: Higher-dose

The validation parameters showed satisfactory linearity in the range of 120 g/mL with a high degree of precision and accuracy

Mounjaro (tirzepatide) is a prescription medicine authorised in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities, as an adjunct to reduced-calorie diet and increased physical activity

Rare but serious effects include pancreatitis risk

Ingredientes: L-Carnitina tartrate, antihumectantes (dixido de silicio, magnesio estearato, calcio tribsico anhidro fosfato)

Symptoms may encompass fatigue, weakness, dyspnea, pallor, and jaundice (11)